查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1931184

生物製药低温运输物流服务市场按服务类型、温度类型、运输方式、产品类型、包装类型和最终用途划分，全球预测（2026-2032年）

Biopharmaceutical Cold Chain Logistics Services Market by Service Type, Temperature Type, Mode Of Transportation, Product Type, Packaging Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物製药低温运输物流服务市场规模将达到 59.2 亿美元，到 2026 年将成长至 65.2 亿美元，到 2032 年将达到 126.2 亿美元，年复合成长率为 11.41%。

关键市场统计数据
基准年 2025 59.2亿美元
预计年份：2026年 65.2亿美元
预测年份 2032 126.2亿美元
复合年增长率 (%) 11.41%

本文从策略角度概述了温度敏感型供应链如何演变为影响临床、监管和商业性结果的关键系统。

生物製药低温运输物流环境是温度敏感型治疗药物交付和商业化的关键因素。从早期临床试验产品的运输到生物製剂、细胞和基因疗法的商业分销，各机构必须兼顾临床需求、监管要求和营运限制，以确保产品完整性。这促使物流供应商、临床试验申办者和生产者重新思考传统模式，并投资于能够扩大规模同时降低风险的能力。

技术日趋成熟、有效载荷日益复杂以及合规性要求不断提高，将把低温运输物流重塑为一个可预测的、数据驱动的配送生态系统。

低温运输物流正经历一场变革，其驱动力包括技术成熟、监管日益严格、温控产品日益复杂。先进的主动包装解决方案和严密的监控技术能够实现持续、高精度的遥测，从而在运输过程中进行主动干预。随着这些功能逐渐成为标准配置，整个生态系统正从被动的异常管理转向基于数据分析的预测性调整，从而实现路线优化、应急计画制定和包装选择。

政策主导的供应链中断和策略采购应对措施凸显了关税变化对温控物流的具体营运影响。

2025年关税和贸易政策变化带来的累积影响将为在国际航线上运营的低温运输物流相关人员带来显着的成本和营运复杂性。关税调整将影响进口包装材料、专用冷冻设备甚至外包服务模组的成本基础，促使供应链重新设计和供应商多元化。因此，进口商和服务供应商需要重新审视采购合同，评估国内采购方案，并权衡对本地资产的资本投资与继续依赖跨境供应商之间的利弊。

全面的細項分析揭示了相互依存的服务、产品和营运要素，这些要素决定了包装、运输和监管策略。

细緻的细分框架揭示了服务产品和产品特性如何影响低温运输系统的营运优先顺序、合约条款和投资需求。根据服务类型，细分领域涵盖包装和监控、法规遵循、仓储和运输。在包装和监控领域，主动包装和被动包装在范围上存在根本差异，资料登录、监控和追踪以及被动解决方案都需要不同的检验途径。主动包装进一步分为冷藏货柜和温控车辆，两者都需要考虑生命週期管理和能源采购。同时，被动包装分为干冰和保温箱，两者各自有其独特的处理、补充和危险物品管理方式。法规遵从服务包括审核、GDP合规性和温度测绘，为连接营运实务和合规要求奠定了至关重要的基础。

区域趋势和基础设施差异将决定全球温控网路中包装、监控和最后一公里配送能力的投资方向。

区域趋势将对美洲、欧洲、中东和非洲以及亚太地区的低温运输物流能力部署和投资重点产生重大影响。在美洲，密集的商业走廊、成熟的临床试验网络以及接近性製造地优势，正在推动快速响应配送模式和主动包装系统的应用。此外，人们越来越关注用于支持先进治疗方法的超低温解决方案，这促使对专用基础设施和「最后一公里」配送能力进行投资。

透过整合包装、检验的监测和专业知识，为高价值生技药品和复杂的临床价值链提供竞争优势。

低温运输物流领域的主要企业透过技术创新、服务整合以及针对高价值、温度敏感货物的专业能力实现差异化竞争。领先的服务供应商强调其检验的包装组合，包括主动冷藏集装箱和优化的被动式解决方案，并辅以即时资料登录和监控系统。这些公司通常整合仓储和运输能力，以减少交接环节并降低温度波动风险，同时也将GDP合规性和温度测绘等监管服务纳入其商业合约中。

透过技术、管治和策略采购选择，提升温控供应链韧性与合规性的实用蓝图

产业领导者应制定切实可行的蓝图，以确保其温控供应链的安全，在降低即时营运风险与长期策略投资之间取得平衡。首先，优先采用可互通的监控平台，产生持续、审核的遥测数据，并支援自动化升级工作流程。这将缩短决策时间，加快偏差反应速度，并建立可用于指导包装选择和运输方式决策的资料集。其次，加快关键包装组件和检验组件的多通路采购，同时对区域供应商进行资格认证，以降低关税影响并缓解物流瓶颈。

一项采用稳健的混合方法的研究，结合了高阶主管访谈、监管分析和横断面细分映射，以检验可操作的低温运输洞察。

本研究整合了一手和二手调查方法，旨在深入了解低温运输物流实践和策略挑战。一手研究包括对供应链主管、品质保证人员、包装工程师和物流营运经理进行结构化访谈，以了解实际营运挑战、检验方法和投资重点。这些访谈内容与二手资讯相结合，包括监管指导文件、行业最佳实践框架、包装和监控技术方面的技术白皮书以及上市公司披露信息，从而全面了解冷链物流的能力和市场动态。

将建构基于整合、敏捷和品质管治的弹性温控供应链网路这一战略要务纳入考量。

这项结论综合分析了影响温敏性治疗药物低温运输物流的技术、监管和商业性趋势的策略意义。随着生物製药、细胞和基因疗法以及全球疫苗接种计画的普及，市场复杂性日益增加，企业再也不能依赖分散的物流模式。相反，企业需要透过整合检验的包装、持续监控和符合监管要求的流程的服务模式来增强韧性，从而确保产品从原产地到患者的完整性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 生物製药低温运输物流服务市场（依服务类型划分）

  • 包装和监测
    • 活性包装
      • 冷藏货柜
      • 温控车辆
    • 资料登录
    • 监测与追踪
    • 被动式封装
      • 干冰
      • 保温箱
  • 监管
    • 审核
    • GDP合规性
    • 温度分布图
  • 贮存
  • 运输

第九章：依温度类型分類的生物製药低温运输物流服务市场

  • 冷冻
  • 冷藏
  • 超低温

第十章 生物製药低温运输物流服务市场（依交通途径）

  • 空运
  • 铁路
  • 道路运输
  • 海上运输

第十一章 生物製药低温运输物流服务市场（依产品类型划分）

  • 细胞和基因治疗
  • 单株抗体
  • 治疗性蛋白质
  • 疫苗

第十二章：依包装类型分類的生物製药低温运输物流服务市场

  • 活动类型
  • 被动的

第十三章 生技製药低温运输物流服务市场（依最终用途划分）

  • 生物製药
  • 临床试验
  • 製药
  • 疫苗

第十四章 生物製药低温运输物流服务市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 生物製药低温运输物流服务市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国生物製药低温运输物流服务市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国生物製药低温运输物流服务市场

第十八章：中国生物製药低温运输物流服务市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • American Airlines Cargo
  • Biocair International Ltd.
  • Cathay Pacific Cargo
  • Cold Chain Technologies, LLC
  • Cryoport, Inc.
  • CSafe Global
  • Envirotainer AB
  • FedEx Corporation
  • KOR Cooler Inc.
  • Kuehne+Nagel International AG
  • LAN Cargo SA
  • LifeConEx LLC
  • Nordic Cold Storage Solutions
  • Pelican BioThermal LLC
  • Singapore Airlines Cargo
  • SkyCell AG
  • Softbox Systems Ltd.
  • Sonoco ThermoSafe
  • United Parcel Service, Inc.
Product Code: MRR-7B550E008DA4

The Biopharmaceutical Cold Chain Logistics Services Market was valued at USD 5.92 billion in 2025 and is projected to grow to USD 6.52 billion in 2026, with a CAGR of 11.41%, reaching USD 12.62 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.92 billion
Estimated Year [2026] USD 6.52 billion
Forecast Year [2032] USD 12.62 billion
CAGR (%) 11.41%

Strategic framing of how temperature-sensitive supply chains have evolved into mission-critical systems shaping clinical, regulatory, and commercial outcomes

The biopharmaceutical cold chain logistics landscape has become a defining factor in the delivery and commercialization of temperature-sensitive therapies. From the earliest clinical trial shipments to commercial distribution of biologics and cell and gene therapies, organizations must reconcile clinical imperatives, regulatory expectations, and operational constraints to protect product integrity. In this context, logistics providers, clinical sponsors, and manufacturers alike are rethinking legacy models and investing in capabilities that reduce risk exposure while enabling scale.

Transitioning from tactical temperature control solutions to vertically integrated, data-rich ecosystems is no longer optional for competitive players. Stakeholders increasingly prioritize end-to-end visibility, validated packaging systems, and regulatory-aligned processes that minimize variability across handoffs. This introduction outlines the drivers that have elevated cold chain logistics from a support function to a strategic differentiator, and sets the stage for deeper analysis of transformative shifts, policy impacts, segmentation nuances, and regional dynamics.

Moving forward, the market will be shaped by the convergence of advanced packaging materials, IoT-enabled monitoring, and a regulatory environment that demands demonstrable chain-of-custody controls. These forces are redefining how product safety, speed-to-market, and cost-efficiency are balanced. The introduction therefore frames the conversation around resilience, compliance, and the operational investments required to meet the needs of next-generation therapeutics.

How technological maturation, payload complexity, and integrated compliance are reshaping cold chain logistics into predictive, data-driven delivery ecosystems

Cold chain logistics is undergoing transformative shifts driven by technological maturation, rising regulatory scrutiny, and the increasing complexity of temperature-sensitive products. Advanced active packaging solutions and rigorous monitoring technologies now provide continuous, high-fidelity telemetry that enables proactive intervention during transit. As these capabilities become standard, the ecosystem is shifting from reactive exception management toward predictive orchestration, where data analytics inform route optimization, contingency planning, and packaging selection.

Concurrently, the nature of payloads is shifting. Cell and gene therapies and personalized medicine introduce variability in vial sizes, dose volumes, and handling instructions, which in turn require bespoke packaging and more frequent controlled-environment transfers. This trend compels logistics providers and sponsors to enhance validation protocols, cold chain qualification exercises, and training programs for handling personnel. In addition, the rise of ultralow temperature therapeutics demands an expanded repertoire of passive and active containment technologies and contingency strategies for long-distance transport.

Another critical shift is the integration of regulatory and quality functions within logistics operations. Temperature mapping, GDP compliance, and auditing are no longer perfunctory checkboxes; they are embedded into contractual service level agreements and performance dashboards. Collaboration between QA/QC teams and logistics operators has intensified, with joint ownership of deviation investigation, root cause analysis, and CAPA implementation. Finally, strategic partnerships and service consolidation are changing the competitive landscape. End users increasingly prefer single-source providers capable of packaging, monitoring, storage, and transport across multiple temperature regimes, reducing handoff risk and streamlining accountability.

Policy-driven supply chain disruption and strategic procurement responses highlighting the tangible operational effects of tariff shifts on temperature-controlled logistics

The cumulative impact of tariffs and trade policy changes in 2025 introduces a material layer of cost and operational complexity for cold chain logistics stakeholders who operate across international corridors. Tariff adjustments can affect the cost basis for imported packaging components, specialized refrigeration equipment, and even outsourced service modules, prompting supply chain redesigns and supplier diversification. Importers and service providers must therefore revisit procurement contracts, evaluate domestic sourcing alternatives, and assess the trade-offs between capital investment in localized assets and continued reliance on cross-border suppliers.

Beyond direct cost implications, tariffs can influence mode selection and routing decisions. Air freight may become less predictable as carriers adjust capacity and pricing strategies; consequently, organizations may accelerate investment in modal flexibility that includes rail and sea alternatives with appropriate temperature control solutions. Where duties change the economics of certain packaging materials or components, the industry may see a shift toward modular design and component standardization that permits local substitution without triggering regulatory requalification.

In parallel, tariff-driven uncertainty increases the value of real-time visibility and scenario modeling. Logistics teams must incorporate tariff scenarios into total landed cost analyses and evaluate the regulatory implications of changing suppliers, particularly for validated components used in GMP environments. To manage risk, stakeholders should prioritize agility in supplier qualification, expand multi-sourcing strategies, and build cross-functional governance that aligns procurement, quality, and logistics decision-making under varying trade regimes. Ultimately, the 2025 tariffs underscore the importance of supply chain resilience and proactive policy monitoring to maintain uninterrupted delivery of temperature-sensitive therapies.

Comprehensive segmentation analysis revealing interdependent service, product, and operational vectors that determine packaging, transport, and regulatory strategies

A nuanced segmentation framework reveals how service offerings and product characteristics shape operational priorities, contractual terms, and investment needs across the cold chain ecosystem. Based on Service Type, the landscape spans Packaging & Monitoring, Regulatory, Storage, and Transport; within Packaging & Monitoring, Active Packaging and Passive Packaging differ fundamentally in operational scope, while Data Logging, Monitoring & Tracking, and Passive solutions require distinct validation pathways. Active Packaging further divides into Refrigerated Containers and Temperature Controlled Vehicles, each demanding lifecycle management and energy sourcing considerations, while Passive Packaging branches into Dry Ice and Insulated Boxes, which carry unique handling, replenishment, and hazardous material controls. Regulatory services encompass Auditing, GDP Compliance, and Temperature Mapping and form an essential overlay that binds operational practice to compliance expectations.

Looking at Temperature Type, Frozen, Refrigerated, and Ultralow regimes impose divergent requirements for containment design, transit duration, and storage infrastructure. Each temperature band affects choice of packaging, monitoring thresholds, and contingency planning. When examined through Mode Of Transportation, differences among Air, Rail, Road, and Sea create variability in transit time, exposure risk, and regulatory touchpoints, and these modal choices interplay with payload characteristics and destination geography.

End Use segmentation shows the distinct expectations of Biologics, Clinical Trials, Pharmaceuticals, and Vaccines, where clinical supply chains emphasize lot integrity and traceability, and commercial distributions emphasize throughput and cost efficiency. Product Type segmentation, including Cell And Gene Therapies, Monoclonal Antibodies, Therapeutic Proteins, and Vaccines, highlights how product stability and delivery modality influence packaging selection and handling protocols. Packaging Type reiterates the Active versus Passive dichotomy with the same Refrigerated Containers, Temperature Controlled Vehicles, Dry Ice, and Insulated Boxes considerations, while Logistics Function segmentation-Inbound, Outbound, and Reverse, with Reverse including Disposal Services and Returns Management-draws attention to lifecycle management and end-of-life handling. Finally, End User segmentation across Contract Logistics Providers, Contract Research Organizations, Pharma Companies, and Research Institutes underscores the differing contractual frameworks, service level expectations, and investment appetites that define customer-provider relationships in the cold chain space.

Synthesizing these segmentation lenses clarifies that decision-making is multivariate: packaging choice is inseparable from temperature type and mode of transport; regulatory services are integral to every segment; and end users vary in their tolerance for operational risk, service consolidation, and capital intensity. Therefore, strategic planning must align across segmentation dimensions to ensure coherence between technical capabilities and commercial commitments.

Regional dynamics and infrastructure disparities that determine where to invest in packaging, monitoring, and last-mile capabilities across global temperature-controlled networks

Regional dynamics materially influence how cold chain logistics capabilities are deployed and how investments are prioritized across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, dense commercial routes, established clinical trial networks, and proximity to manufacturing hubs favor rapid-response distribution models and significant adoption of active packaging systems. This region also shows a growing emphasis on ultralow temperature solutions to support advanced therapies, which in turn drives investments in specialized infrastructure and last-mile capabilities.

In Europe, Middle East & Africa, regulatory harmonization efforts and cross-border trade complexities encourage a strong focus on GDP compliance, temperature mapping, and audited storage solutions. The EMEA region features a diverse set of infrastructure capabilities, where mature Western European markets often push for high-touch service integration while certain emerging markets require targeted investments to standardize handling and monitoring practices. Regulatory convergence and the need for validated cross-border transit corridors make collaboration among logistics providers, regulators, and manufacturers particularly important.

Asia-Pacific presents a unique combination of rapid demand growth, manufacturing scale-up, and logistical diversity. The region's heterogeneity necessitates flexible mode-of-transport strategies that integrate air, sea, and road solutions while accommodating variable cold storage capabilities at origin and destination points. Public sector investments in healthcare infrastructure and the expansion of regional distribution hubs are accelerating adoption of both passive and active packaging technologies, especially where domestic production of biologics and vaccines is increasing. Across all regions, the interplay between infrastructure maturity, regulatory frameworks, and demand profiles informs where to locate assets, which partnerships to pursue, and how to prioritize investments in monitoring, packaging, and staffing.

Competitive differentiation through integrated packaging, validated monitoring, and specialized capabilities that support high-value biologics and complex clinical supply chains

Key companies operating within cold chain logistics are differentiating through a combination of technological innovation, service integration, and specialized capabilities tailored to high-value, temperature-sensitive payloads. Leading service providers emphasize validated packaging portfolios that include both active refrigerated containers and optimized passive solutions, supported by real-time data logging and monitoring systems. These firms typically combine storage and transport capabilities to reduce handoffs and limit exposure to temperature excursions, while embedding regulatory services such as GDP compliance and temperature mapping into commercial agreements.

Other notable players specialize in niche capabilities such as ultralow temperature storage, clinical trial logistics, or reverse logistics for returns and disposal services. These companies often partner with device manufacturers, packagers, and local carriers to expand geographic reach without diluting technical control. Strategic differentiation also comes through digital platforms that provide end-to-end visibility, predictive alerts, and analytics to demonstrate chain-of-custody and support deviation investigations. Investment in personnel training, accredited auditing teams, and quality systems reinforces commercial credibility, particularly for customers handling cell and gene therapies or large-scale vaccine programs.

Across the competitive landscape, alliances between packaging innovators, monitoring technology vendors, and logistics operators are becoming more common as stakeholders pursue integrated offers that simplify procurement and provide single-vendor accountability. For buyers, the selection criteria increasingly emphasize not only cost and capacity but also validation history, incident response capabilities, and the ability to scale services to meet evolving product and market complexity.

Actionable roadmap for strengthening resilience and compliance in temperature-controlled supply chains through technology, governance, and strategic sourcing choices

Industry leaders should adopt a pragmatic roadmap that balances immediate operational risk reduction with longer-term strategic investments to secure temperature-controlled supply chains. First, prioritize deployment of interoperable monitoring platforms that generate continuous, auditable telemetry and support automated escalation workflows. This will reduce dwell time in decision-making, accelerate deviation resolution, and create datasets that inform packaging selection and modal decisions. Second, accelerate multi-sourcing of critical packaging components and validated assemblies while qualifying regional suppliers to reduce tariff sensitivity and logistics bottlenecks.

Third, invest in training programs and joint governance structures that align quality, procurement, and logistics functions under unified SOPs and KPI frameworks. This cross-functional alignment ensures that regulatory compliance drives operational decisions and that deviations trigger coordinated CAPA initiatives rather than siloed investigations. Fourth, evaluate the business case for localized ultralow and refrigerated infrastructure in high-demand markets to reduce time-in-transit risk and improve responsiveness for advanced therapies. Fifth, pursue commercial models that bundle packaging, monitoring, storage, and transport to limit handoffs and create single points of accountability, while negotiating clear SLAs and performance penalties for temperature excursions.

Finally, embrace scenario planning that incorporates tariff fluctuations, modal disruptions, and regulatory changes to inform contingency playbooks. By stress-testing network design and running tabletop exercises, leaders can validate redundancy, clarify escalation paths, and ensure that contractual mechanisms support rapid response. Together, these actions will reduce product risk exposure, enhance regulatory readiness, and create operational agility necessary for the next generation of biologics and personalized therapies.

Robust mixed-methods research design combining executive interviews, regulatory analysis, and cross-sectional segmentation mapping to validate actionable cold chain insights

This research integrates primary and secondary data collection methodologies to produce evidence-based insights into cold chain logistics practices and strategic imperatives. Primary research included structured interviews with supply chain executives, quality assurance leaders, packaging engineers, and logistics operations managers to capture frontline operational challenges, validation approaches, and investment priorities. These conversations were synthesized with secondary sources such as regulatory guidance documents, industry best-practice frameworks, technical white papers on packaging and monitoring technologies, and publicly available corporate disclosures to construct a holistic view of capabilities and market dynamics.

The analytical approach involved cross-sectional segmentation mapping to identify how service types, temperature regimes, modes of transport, and end-use cases interact to shape operational requirements. Case studies were developed to illustrate successful integration of active and passive packaging strategies, regulatory compliance programs, and multimodal routing. Data triangulation ensured that qualitative findings were corroborated by documented protocol standards and technology specifications. Wherever possible, validation steps included follow-up interviews and peer review from subject matter experts to confirm accuracy and applicability of conclusions.

Limitations are acknowledged, particularly where proprietary commercial arrangements or novel proprietary technologies limit disclosure. To mitigate this, the methodology emphasizes pattern recognition across multiple independent sources and prioritizes examples that demonstrate replicable practices. The resulting methodology provides a robust foundation for the report's strategic recommendations and regionally informed insights, while offering transparency about data provenance and analytical assumptions.

Synthesis of strategic imperatives emphasizing integration, agility, and quality governance as the foundation for resilient temperature-controlled supply networks

The conclusion synthesizes the strategic implications of technological, regulatory, and commercial trends shaping cold chain logistics for temperature-sensitive therapies. As market complexity intensifies with the proliferation of biologics, cell and gene therapies, and global vaccination programs, organizations can no longer rely on siloed logistics practices. Instead, resilience will be delivered through integrated service models that combine validated packaging, continuous monitoring, and regulatory-aligned processes to ensure product integrity from origin to patient.

Moreover, the dual pressures of policy change and evolving payload characteristics demand proactive supply chain design. Firms that invest early in interoperable data platforms, multi-sourced validated components, and localized infrastructure where appropriate will be better positioned to absorb shocks, adapt to tariff and modal shifts, and support rapid scale-up for clinical and commercial launches. Collaboration across industry participants-including shippers, packagers, carriers, and regulatory stakeholders-will accelerate standardization and reduce friction at international handoffs. Ultimately, the strategic winners will be those who treat cold chain logistics as a core competency, embedding quality and agility into every tier of their distribution networks to protect product value and patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical Cold Chain Logistics Services Market, by Service Type

  • 8.1. Packaging & Monitoring
    • 8.1.1. Active Packaging
      • 8.1.1.1. Refrigerated Containers
      • 8.1.1.2. Temperature Controlled Vehicles
    • 8.1.2. Data Logging
    • 8.1.3. Monitoring & Tracking
    • 8.1.4. Passive Packaging
      • 8.1.4.1. Dry Ice
      • 8.1.4.2. Insulated Boxes
  • 8.2. Regulatory
    • 8.2.1. Auditing
    • 8.2.2. GDP Compliance
    • 8.2.3. Temperature Mapping
  • 8.3. Storage
  • 8.4. Transport

9. Biopharmaceutical Cold Chain Logistics Services Market, by Temperature Type

  • 9.1. Frozen
  • 9.2. Refrigerated
  • 9.3. Ultralow

10. Biopharmaceutical Cold Chain Logistics Services Market, by Mode Of Transportation

  • 10.1. Air
  • 10.2. Rail
  • 10.3. Road
  • 10.4. Sea

11. Biopharmaceutical Cold Chain Logistics Services Market, by Product Type

  • 11.1. Cell & Gene Therapies
  • 11.2. Monoclonal Antibodies
  • 11.3. Therapeutic Proteins
  • 11.4. Vaccines

12. Biopharmaceutical Cold Chain Logistics Services Market, by Packaging Type

  • 12.1. Active
  • 12.2. Passive

13. Biopharmaceutical Cold Chain Logistics Services Market, by End Use

  • 13.1. Biologics
  • 13.2. Clinical Trials
  • 13.3. Pharmaceuticals
  • 13.4. Vaccines

14. Biopharmaceutical Cold Chain Logistics Services Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biopharmaceutical Cold Chain Logistics Services Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biopharmaceutical Cold Chain Logistics Services Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Biopharmaceutical Cold Chain Logistics Services Market

18. China Biopharmaceutical Cold Chain Logistics Services Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. American Airlines Cargo
  • 19.6. Biocair International Ltd.
  • 19.7. Cathay Pacific Cargo
  • 19.8. Cold Chain Technologies, LLC
  • 19.9. Cryoport, Inc.
  • 19.10. CSafe Global
  • 19.11. Envirotainer AB
  • 19.12. FedEx Corporation
  • 19.13. KOR Cooler Inc.
  • 19.14. Kuehne + Nagel International AG
  • 19.15. LAN Cargo S.A.
  • 19.16. LifeConEx LLC
  • 19.17. Nordic Cold Storage Solutions
  • 19.18. Pelican BioThermal LLC
  • 19.19. Singapore Airlines Cargo
  • 19.20. SkyCell AG
  • 19.21. Softbox Systems Ltd.
  • 19.22. Sonoco ThermoSafe
  • 19.23. United Parcel Service, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 214. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 247. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 250. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2